Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06360562 · ClinicalTrials.gov registry record · NA
Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)
A NA study of Anxiety Disorders and Mood Disorders, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 174
- Enrollment target
- 1
- Study location
NCT06360562: Active NA study of Anxiety Disorders and Mood Disorders, sponsored by Massachusetts General Hospital.
NCT06360562 is a NA study of Anxiety Disorders and Mood Disorders that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 174 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06360562, a NA study of Anxiety Disorders and Mood Disorders, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 174 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aimed to determine the feasibility and acceptability of delivering Resilience Training in multi-user virtual reality.
Primary Outcome
Discomfort with others is measured on a brief scale rated on a Likert scale of 1-5, asking three questions, how frequently someone feels discomfort with others, how intensely they feel it, and a multiple choice selection of reasons they may feel discomfort with others. Higher ratings indicate more discomfort with others.
Conditions Studied
Interventions
- BEHAVIORAL Resilience Training
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT06360562 still lists
NCT06360562 is an interventional study that assigns participants to a tested intervention. The registered 174 participants enrollment target is mid-sized for trials with a published cap, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Resilience Training is the first listed.
NCT06360562 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06360562 about?
NCT06360562 is a clinical study titled "Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)". This study aimed to determine the feasibility and acceptability of delivering Resilience Training in multi-user virtual reality.
What is the current status of trial NCT06360562?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 174 participants. The study started on 2020-09-15. Estimated completion is 2025-12-31.
What conditions does trial NCT06360562 study?
This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders, Psychotic Disorders.
What interventions are being tested in trial NCT06360562?
The interventions under investigation include: Resilience Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06360562?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06360562 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06360562's enrollment target sits among peer trials
174 29th of 84 higher than 56 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01000259 · 174 participants
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- NCT04729114 · 174 participants · Phase 1
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- NCT04884035 · 174 participants · Phase 1
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
- NCT05075980 · 174 participants · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI